10 years of experience

Graftys is an innovation-driven Medtech company committed to the development and manufacturing of synthetic bone biomaterials. Graftys markets products covered by a large patent portfolio in more than 25 countries throughout the world, with regulatory approvals in Europe, the USA, Canada, North and South America and Australia.



Graftys bone cements are injectable, self-hardening, macroporous, calcium-phosphate bonevoid fillers.


Graftys ceramics offer a variety of synthetic and bioresorbable bone graft substitutes with a wide range of porosity optimized for bone void filling.